胱抑素C在评估冠心病危险程度中的临床价值分析被引量：2

下载PDF

导出

摘要目的探讨血清胱抑素C(Cys C)水平在评估冠状动脉粥样硬化性心脏病(冠心病)患者危险程度中的价值。方法分析确诊为冠心病的89例患者临床资料,应用免疫比浊法检测血清胱抑素C浓度,探讨血清胱抑素C水平在冠心病患者中与冠状动脉病变支数及冠心病病情等方面的关系;分析冠心病相关危险因素对其的影响。ROC曲线分析Cys C在冠心病诊断中可能价值。结果冠心病组血浆Cys C水平高于对照组,具有统计学意义(P<0.05)。血清Cys C水平与冠心病患者病情相关,其水平升高与冠状动脉病变支数正相关。冠心病相关危险因素中年龄、高脂血症史及糖尿病史与患者的Cys C水平相关。Cys C预测冠心病的敏感性为62.0%,特异性为96.7%。结论 Cys C和与冠状动脉病变程度密切相关,可能是冠心病一个预测因素,值得相关学者做进一步深入研究。

作者陈积党

机构地区浙江省平阳县人民医院心血管内科

出处《齐齐哈尔医学院学报》 2015年第33期5051-5052,共2页 Journal of Qiqihar Medical University

关键词冠心病胱抑素C

分类号 R692 [医药卫生—泌尿科学]

引文网络
相关文献

参考文献7

1Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk [ J ]. Clin Chem,2009,55 ( 11 ) : 1932-1943.
2Lassus J,Harjola VP. IEystatin C:a step forward in assessing kidney function and cardiovascular risk [ J ]. Heart Fail Rev, 17 ( 2 ) : 251 - 261.
3Odutayo A, Cherney D. Cystatin C and acute changes in glomerular filtration rate [ J 1- Clirt Nephrol,2012,78 ( 1 ) :64-75.
4Ferraro S, Marano G, Biganzoli EM, Boracchi P, Bongo AS. Prognostic value of cystatin C in acute coronary syndromes : enhancer of atherosclerosis and promising therapeutic target [ J ]. Clin Chem Lab Med,2011,49 (9) : 1397-1404.
5Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk [ J ]. Clin Chem 2009, 55 ( 11 ) : 1932-1943.
6Kiyosue A, Hirata Y, Ando J, et al. Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease [ J ]. Cire J, Nov,2010,74 ( 11 ) :2441-2447.
7孙磊,杨志健,贾恩志.冠心病患者血清胱抑素C水平及其影响因素分析[J].中国动脉硬化杂志,2011,19(12):1024-1028. 被引量：30

二级参考文献15

1韩平治,丁进芳,张翀,司玉春.兰州市健康人血清胱抑素C浓度参考范围的调查[J].国际检验医学杂志,2006,27(2):176-176. 被引量：18
2胡欣,徐岩,史学功,吴继雄,汪太平,于芳,程自平.CystatinC、Hcy及TNF-α在慢性心力衰竭患者血清中的表达变化[J].中国现代医学杂志,2006,16(23):3604-3606. 被引量：9
3董巧玲,刘俊.急性心肌梗死患者血清Cystatin C的变化[J].中国心血管病研究,2007,5(1):27-29. 被引量：19
4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量：5230
5Koenig W, Twardella D, Brenner H, et al. Plasma con- centration of cystatin C in patients with coronary heart dis- ease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate [ J ]. Clin Chem, 2005, 51 (2): 321-327.
6Noto D, Cefalu AB, Barbagallo CM, et al. Cystatin C lev- els are decreased in acute myocardial infarction. Effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardiol, 2005, 101 (2) : 213-217.
7Expert Committee on the diagnosis and classification of dia- betes mellitus. Report of the expert committee on diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2003, 26(supl) :S5-S20.
8Anastasi A, Brown MA, Kembhavi AA, et al. Cystatin, a protein inhibitor of cysteine proteinase. Improved purifica- tion from egg white, Characterization, and detection in chicken serum[J]. Bioehem J, 1983, 211 (1) : 129-138.
9Jernberg T, Lindahl B, James S, et al. Cystatin C: a no- vel predictor of outcome in suspected or confirmed non-ST- elevation acute coronary syndrome [ J ]. Circulation, 2004, 110 (16) : 2 342-348.
10Shlipak MG, Katz R, Fried LF, et al. Cystatin C and mortality in elderly persons with heart failure [ J ]. J Am Coll Cardiol, 2005, 45 (2): 268-271.